Advertisement
U.S. markets closed

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
8.68+0.28 (+3.27%)
At close: 04:00PM EST
8.69 +0.01 (+0.12%)
After hours: 07:57PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
52
426
-68
4,410
8,185
Operating Expense
99,562
83,936
87,672
89,954
62,984
Operating Income
-99,510
-83,510
-87,740
-85,544
-54,799
Net Non Operating Interest Income Expense
8,459
7,316
2,862
198
313.093
Other Income Expense
-12,469
-12,253
-32
-11,744
24.147
Pretax Income
-103,520
-88,447
-84,910
-97,090
-54,462
Tax Provision
-
0
-197
0
-5,417
Net Income Common Stockholders
-103,520
-88,447
-84,713
-97,090
-49,044
Diluted NI Available to Com Stockholders
-103,520
-88,447
-84,713
-97,090
-49,044
Basic EPS
-1.54
-1.66
-1.81
-2.35
-1.91
Diluted EPS
-1.54
-1.66
-1.81
-2.35
-1.91
Basic Average Shares
51,137
53,247
46,926
41,283
25,637
Diluted Average Shares
51,137
53,247
46,926
41,283
25,637
Total Operating Income as Reported
-111,929
-95,929
-87,740
-96,914
-54,799
Total Expenses
99,562
83,936
87,672
89,954
62,984
Net Income from Continuing & Discontinued Operation
-103,520
-88,447
-84,713
-97,090
-49,044
Normalized Income
-91,101
-76,028
-84,713
-85,720
-49,044
Interest Income
8,469
7,351
2,870
203
322.514
Interest Expense
10
35
8
5
9.421
Net Interest Income
8,459
7,316
2,862
198
313.093
EBIT
-103,510
-88,412
-84,902
-97,085
-54,452
EBITDA
-103,191
-87,935
-84,409
-96,534
-54,023
Reconciled Depreciation
319
477
493
551
428.878
Net Income from Continuing Operation Net Minority Interest
-103,520
-88,447
-84,713
-97,090
-49,044
Total Unusual Items Excluding Goodwill
-12,419
-12,419
0
-11,370
0
Total Unusual Items
-12,419
-12,419
0
-11,370
0
Normalized EBITDA
-90,772
-75,516
-84,409
-85,164
-54,023
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0